Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-10

Clinical Trial Update: Perioperative Pregabalin for Reducing Opioid Consumption After Cardiac Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating perioperative pregabalin to reduce opioid consumption after cardiac surgery; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Opioid Use | Phase 3 | Status: TERMINATED